RSS

CYDY CytoDyn Inc

Mod: mightycydy Asst: HHIGambler,CaptnAmerca
Last Post: 4:37 PM
Followers: 436
Posts Today: 12
Views Today: 24865

CYDY Stock Quote & Tools

$0.2000 ▲ +0.0010 (+0.50%) As of Oct 2, 3:59 PM EDT
Last0.2000
$ Chg0.0010
Open0.1900
High0.2070
Beta1.4964
Year High0.397
Market Cap293.90M
P/B Ratio-2.75
EPS-0.03
Avg Vol (30d)1.62M
Volume1.53M
% Chg+0.50%
Prev Close0.1990
Low0.1900
VWAP0.20048
Year Low0.183
Total Shares1.47B
Shares Out1.47B
Float1.36B
ExchangeOTCQB
Healthcare Biotechnology & Life Sciences
Company Profile Buy Rating Time & Sales News Filings Financials

CYDY Stock Message Board Discussion

3 Pinned Posts
Leronlimab (Pro 140) Cliff Notes What is it? Leronlimab is a humanized monoclo (43) by trding
Leronlimab Regulator List (a work in progress) = upregulation = downregulation a-SMA (21) by ohm20
EIND: Information to Submit to Doctors Leronlimab a humanized monoclonal antibody binds CCR5, (38) by ohm20
  1. SeekingAlfa

    They keep doing these conference calls and the stock will dwindle down to nothing. Down $.66 last

    (2)
  2. my2centz

    Is the CD12 1:1 or 2:1 assignment? I cannot tell from the trial design site. CD10 clearly stated

  3. viridi

    He said he doesnt know which arm the deaths were in, it is a blinded study.

  4. z_smith01

    Rough notes from Q&A: Q: UK Updates? A: Working to get 1st pt enrolled 10/22 is CYDY hope

    (16)
  5. lagrange

    NP said that BP's occupancy test were not approved by FDA and need to be redone with a different

    (1)
  6. reallypeople?

    Near the end NP addressed the 45 deaths ,but i couldnt understand what he said . Who can clarify

  7. docj

    I liked the format too. Time saver. More questions were answered.

  8. I_luv_cydy

    The questions were much better on this call. And the woman asking them did a great job reading

    (5)
  9. DaveEL

    Kudos to those who submitted questions! These are great questions and I think this format should be

    (2)
  10. datapoint

    I was a little late for the call... any news on uplisting?

  11. bigO

    NP is 100% confident BLA approval!!! I think I heard a "100%" in December 2019 meeting to question

  12. CDiddy

    Im not leaving entirely. I just cant spend as much time here anymore. Ill be around and I hope

    (2)
  13. crazyjogger925

    dr kelly just answered question re license agreements and said cydy working/talking with 11

    (1)
  14. Boatbuilder

    Buying opportunity.

  15. bigO

    I see is blaming the receptor occupancy missing data on Bruce P. SMH. I wonder when NP knew

  16. Borel Fields

    CDiddy - Thanks so much for the work you put in and the stress you absorbed to keep this board

    (7)
  17. penniestodimes

    CDiddy removes himself as a mod, and the SP drops like a rock! Don't gooooo!

    (2)
  18. CTMedic

    I appreciate everyones frustration, but if we prove in a P3 trial with a severe indication, even

    (3)
  19. Riztheinvestor

    Right !

  20. Evil Rabbit

    Under $3.

  21. crazyjogger925

    sorry about your family health issues hope they get better.you did a good mod

  22. SumDudeOnline

    The FDA would be very impressed and have us run a 500 patient confirmatory P3 after this one

    (1)
  23. CTMedic

    50% reduction, (23 leronlimab, 22 placebo) is p=0.012. The higher the proportion in placebo, the

    (6)
  24. Riztheinvestor

    And yes thank you !

  25. mountaineer

    AGREE

  26. aidenb

    Good thinking. Nothing to track here. Let it take it's course. Cheers... and

  27. nmbr1stckpckr

    thank you for your service.

    (2)
  28. CDiddy

    All, I have removed myself as a Mod. Nothing to do with yall, but I am at a point where I have to

    (27)
  29. Riztheinvestor

    Ok so what if almost all 45 died that werent given Leronlimab. What would be the P value and

  30. Bored Lawyer

    I was unable to listen. can anyone else on the board please add additional clarity to this point?

  31. CTMedic

    45 deaths in CD12 (bad for patients, great for trial) I believe (Techguru, Borel or others can

    (6)
  32. bigO

    First I have heard we don't have the receptor occupancy data for BLA. Did I hear that right? Or was

    (1)
  33. crazyjogger925

    if a deal happens in asia lots of eyes will be watching will be important.imo

    (1)
  34. reallypeople?

    Skipped right over 45 deaths approx .. Is that a guess by them ?????

    (1)
  35. nmbr1stckpckr

    Can't be a priorty when resources are limited and you don't want to give up on anything in the

    (1)
  36. Riztheinvestor

    Yea agree where is cancer ?

  37. Cycl2R

    Listening right now to Nader on our share price and looking at the CYDY terrifying 3 month chart I

    (1)
  38. Bored Lawyer

    You mean just like the memorandum of understanding with Thailand to do the HIV prep study? (Not

    (2)
  39. NICKIE

    TSK! TSK! TSK! Proposals approved. Issued stock should have been used for

    (1)
  40. crazyjogger925

    agreement in philippines to be announced next couple days per np

  41. LOL83001

    Here is link to PP

  42. Bored Lawyer

    Last slide... So cancer is not a priority?

    (1)
  43. lorbas

    45 overall deaths in CD-12; presentation posted:

  44. nmbr1stckpckr

    has it started yet? All I see is a spinning wheel....

  45. docj

    http://archive.fast-edgar.com/20200930/AP2BQ22EZZ2RD2ZZ2RJM22YSBOKGZZ22Z222/

  46. HCIT

    Looks to me that the shorts are piling in backing up against 3.00-3.01. I sure hope this meeting

  47. MIAS&M

    Of course, neither password: CYDY2020 nor the control number___ works... Same here, I signed in

  48. LaundryMoney

    Whew. Just dodged a bullet. Easy listening music instead of classical playing on the call and at

    (4)
  49. gestalt2

    seriously? Dr Patterson has said in the past that lerolimab is key in restoring to normal immune

    (5)
  50. CaptnAmerca

    I've never gotten one of these to work as a shareholder. Never. Logging in as a guest is the

    (2)

Top 10 Most Recent News Articles

More News Articles

Top 5 Most Recently Viewed Articles

Bear Unveils Enhanced Digital Solutions with New Leadership

Updated Category News Views 262

Bear Elevates Leadership to Drive Digital Innovation Bear, a vibrant digital commerce agency, has unveiled an exciting new direction that features fresh leadership alongside a powerful brand strategy. Their mission is to empower brands to grow and scale, and they are thrilled to announce that Mick McCarthy is joining as their Chief Design Officer (CDO). This appointment...

Continue Reading
SalMar ASA Announces Successful Green Bond Tap Issue

Updated Category News Views 170

SalMar ASA's Strategic Green Bond Issuance Today, SalMar ASA, a prominent player in the aquaculture industry, has made headlines by successfully tapping into the green bond market with an additional NOK 500 million issuance. This move is a part of their proactive approach to finance sustainable initiatives while maintaining robust financial health. Details of the New...

Continue Reading
Bassett Furniture Navigates Challenges in Q3 Financials

Updated Category News Views 128

Bassett Furniture's Financial Overview for Q3 Bassett Furniture Industries, Inc. (NASDAQ: BSET) shared its operating results for the latest fiscal third quarter. The company announced a quarterly dividend of $0.20 per share, showcasing a commitment to rewarding its shareholders amidst challenging market conditions. This dividend marks an 11% increase compared to the...

Continue Reading
Appian Set to Lead Discussions at Major Investor Conferences

Updated Category News Views 109

Appian’s Upcoming Investor Conferences Appian is gearing up for some major opportunities to connect with investors in the technology sector. With a commitment to transparency and communication, the company will be participating in prestigious investor conferences where they will present their innovations and interact with institutional investors directly. Scotiabank...

Continue Reading
Attorney Davis Explores Legal Actions Against Liberty's Company

Updated Category News Views 495

Upcoming National Tele Press Conference by Lanny J. Davis Lanny J. Davis, a prominent attorney and spokesperson, has announced an important national tele press conference. This event is aimed at shedding light on the lawsuits filed against a company controlled by Michael Liberty, focusing on ongoing legal challenges related to these cases. Key Discussion Points of the...

Continue Reading